FTRE
Fortrea Holdings Inc.
NASDAQ: FTRE · HEALTHCARE · BIOTECHNOLOGY
$11.50
+8.90% today
Updated 2026-04-30
Market cap
$998.82M
P/E ratio
—
P/S ratio
0.37x
EPS (TTM)
$-10.81
Dividend yield
—
52W range
$4 – $19
Volume
1.5M
Fortrea Holdings Inc. (FTRE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-36.20%
Operating margin
1.33%
ROE
-102.40%
ROA
-0.61%
Debt/equity
2.04x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $2.58B | $-359.20M | 18.96% | -12.18% | -13.92% |
| 2021 | $3.06B | $98.00M | 19.77% | 3.74% | 3.21% |
| 2022 | $2.84B | $186.20M | 25.53% | 6.59% | 6.56% |
| 2023 | $2.84B | $-25.20M | 20.78% | 1.13% | -0.89% |
| 2024 | $2.70B | $-328.50M | 19.81% | -6.00% | -12.18% |
| 2025 | $2.72B | $-986.20M | 15.63% | -1.12% | -36.21% |